175 related articles for article (PubMed ID: 11263934)
1. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging.
Umesaki N; Tanaka T; Miyama M; Kawamura N; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
Gynecol Oncol; 2001 Mar; 80(3):372-7. PubMed ID: 11263934
[TBL] [Abstract][Full Text] [Related]
2. Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas.
Murakami M; Tsukada H; Shida M; Watanabe M; Maeda H; Koido S; Hirasawa T; Muramatsu T; Miyamoto T; Nasu S; Yasuda S; Kajiwara H; Yasuda M; Ide M
Int J Gynecol Cancer; 2006; 16(2):854-60. PubMed ID: 16681773
[TBL] [Abstract][Full Text] [Related]
3. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
[TBL] [Abstract][Full Text] [Related]
4. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
[TBL] [Abstract][Full Text] [Related]
5. Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
Sharma P; Kumar R; Singh H; Jeph S; Sharma JB; Jain SK; Sharma DN; Bal C; Malhotra A
Nucl Med Commun; 2012 Feb; 33(2):185-90. PubMed ID: 22107993
[TBL] [Abstract][Full Text] [Related]
6. ¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma.
Inoue K; Tsubamoto H; Kawata S; Hao H; Ikeda Y; Oku N; Hirota S
J Obstet Gynaecol Res; 2014 Feb; 40(2):576-82. PubMed ID: 24118160
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-D-glucose in the diagnosis of uterine leiomyosarcoma: a case report.
Umesaki N; Tanaka T; Miyama M; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
Clin Imaging; 2001; 25(3):203-5. PubMed ID: 11679229
[TBL] [Abstract][Full Text] [Related]
8. Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas.
Nagamatsu A; Umesaki N; Li L; Tanaka T
Oncol Rep; 2010 Apr; 23(4):1069-76. PubMed ID: 20204293
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.
Sadeghi R; Zakavi SR; Hasanzadeh M; Treglia G; Giovanella L; Kadkhodayan S
Int J Gynecol Cancer; 2013 Oct; 23(8):1349-56. PubMed ID: 23945203
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging features of uterine sarcoma and mimickers.
Barral M; Placé V; Dautry R; Bendavid S; Cornelis F; Foucher R; Guerrache Y; Soyer P
Abdom Radiol (NY); 2017 Jun; 42(6):1762-1772. PubMed ID: 28246921
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma.
Ho KC; Lai CH; Wu TI; Ng KK; Yen TC; Lin G; Chang TC; Wang CC; Hsueh S; Huang HJ
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):484-92. PubMed ID: 17952435
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
13. Current Status of Magnetic Resonance Imaging in Patients with Malignant Uterine Neoplasms: A Review.
Huang YT; Huang YL; Ng KK; Lin G
Korean J Radiol; 2019 Jan; 20(1):18-33. PubMed ID: 30627019
[TBL] [Abstract][Full Text] [Related]
14. Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
Tsujikawa T; Yoshida Y; Mori T; Kurokawa T; Fujibayashi Y; Kotsuji F; Okazawa H
Radiology; 2008 Aug; 248(2):599-605. PubMed ID: 18539894
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/MRI in Synchronous Uterine Adenocarcinoma and Leiomyosarcoma.
Yokoo S; Zeng F; Nogami M; Ueno YR; Murakami T
Clin Nucl Med; 2022 Jun; 47(6):e452-e454. PubMed ID: 35353760
[TBL] [Abstract][Full Text] [Related]
16. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Bredella MA; Caputo GR; Steinbach LS
AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of FDG PET/CT findings of uterine tumors.
Kitajima K; Murakami K; Kaji Y; Sugimura K
AJR Am J Roentgenol; 2010 Sep; 195(3):737-43. PubMed ID: 20729454
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report.
Zhang HJ; Zhan FH; Li YJ; Sun HR; Bai RJ; Gao S
Chin Med J (Engl); 2011 Jul; 124(14):2237-40. PubMed ID: 21933635
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomographic-computed tomographic imaging of a uterine sarcoma.
Cher S; Lay Ergun E
Clin Nucl Med; 2003 May; 28(5):443-4. PubMed ID: 12702956
[No Abstract] [Full Text] [Related]
20. MRI appearance of mesenchymal tumors of the uterus.
Cornfeld D; Israel G; Martel M; Weinreb J; Schwartz P; McCarthy S
Eur J Radiol; 2010 Apr; 74(1):241-9. PubMed ID: 19349135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
